Pliant Therapeutics (PLRX) Asset Utilization Ratio (2020 - 2024)
Pliant Therapeutics (PLRX) reported Asset Utilization Ratio of 0.0 for Q1 2024, down 97.67% year-over-year from 0.02 in Q2 2023, and down 84.02% quarter-over-quarter from 0.0 in Q4 2023.
Pliant Therapeutics (PLRX) Asset Utilization Ratio (2020 - 2024) Analysis & Trends
Pliant Therapeutics (PLRX) has 5 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2024.
- Asset Utilization Ratio for Q1 2024 came in at 0.0, down 97.67% year-over-year; the trailing twelve-month figure through Mar 2024 was 0.0 (down 97.67% YoY), and the FY2023 annual result was 0.0, down 89.19% from the prior year.
- Asset Utilization Ratio slipped to 0.0 in Q1 2024 per PLRX's latest filing, from 0.0 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.14 in Q4 2020 and troughed at 0.0 in Q1 2024.
- A 5-year average of 0.04 and a median of 0.03 in 2021 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio grew 3.46% in 2022, then tumbled 97.67% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.14 in 2020, then tumbled by 75.83% to 0.03 in 2021, then slipped by 19.98% to 0.03 in 2022, then tumbled by 88.72% to 0.0 in 2023, then sank by 84.02% to 0.0 in 2024.
- Business Quant data shows PLRX's Asset Utilization Ratio at 0.0 in Q1 2024, 0.0 in Q4 2023, and 0.01 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 0.55 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.05 |
| Dec 31, 2020 | 0.14 |